Compare Stocks

→ Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGNOF DIAGNOS	$0.22 +4.7%	$0.21	$0.18 ▼ $0.43	$17.05M	0.2	23,598 shs	27,500 shs
OROXF Orosur Mining	$0.19	$0.14	$0.06 ▼ $0.19	$39.16M	-0.01	N/A	N/A
RNUGF ReNeuron Group	$0.00	$0.04	$0.00 ▼ $0.05	$63K	0.52	126 shs	N/A
WCAGY Wirecard	$0.00	$0.00	$0.00 ▼ $0.29	$494K	0.15	9,083 shs	N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGNOF DIAGNOS	+2.87%	+1.60%	+11.20%	-18.68%	+13.35%
OROXF Orosur Mining	0.00%	0.00%	0.00%	+233.80%	+281.00%
RNUGF ReNeuron Group	0.00%	-97.41%	-97.41%	-97.86%	-98.78%
WCAGY Wirecard	0.00%	0.00%	0.00%	0.00%	0.00%

Biden out June 13; Kamala won’t replace him? (Ad)

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DGNOF DIAGNOS	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OROXF Orosur Mining	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RNUGF ReNeuron Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WCAGY Wirecard	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGNOF DIAGNOS	N/A	N/A	N/A	N/A
OROXF Orosur Mining	N/A	N/A	N/A	N/A
RNUGF ReNeuron Group	N/A	N/A	N/A	N/A
WCAGY Wirecard	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGNOF DIAGNOS	$370K	46.07	N/A	N/A	($0.02) per share	-11.12
OROXF Orosur Mining	N/A	N/A	N/A	N/A	($0.04) per share	N/A
RNUGF ReNeuron Group	$640K	0.10	N/A	N/A	$0.11 per share	0.01
WCAGY Wirecard	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGNOF DIAGNOS	-$1.88M	-$0.04	N/A	∞	N/A	-1,553.79%	N/A	-297.10%	N/A
OROXF Orosur Mining	-$1.79M	-$0.01	N/A	∞	N/A	N/A	N/A	-20.69%	N/A
RNUGF ReNeuron Group	-$6.52M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
WCAGY Wirecard	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest OROXF, RNUGF, WCAGY, and DGNOF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/28/2024	Q3 2024	DGNOF DIAGNOS	N/A	-$0.01	-$0.01	-$0.01	N/A	$0.04 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGNOF DIAGNOS	N/A	N/A	N/A	N/A	N/A
OROXF Orosur Mining	N/A	N/A	N/A	N/A	N/A
RNUGF ReNeuron Group	N/A	N/A	N/A	N/A	N/A
WCAGY Wirecard	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGNOF DIAGNOS	N/A	0.79	0.79
OROXF Orosur Mining	N/A	0.23	0.23
RNUGF ReNeuron Group	0.08	1.51	N/A
WCAGY Wirecard	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DGNOF DIAGNOS	N/A
OROXF Orosur Mining	N/A
RNUGF ReNeuron Group	N/A
WCAGY Wirecard	N/A

Insider Ownership

Company	Insider Ownership
DGNOF DIAGNOS	N/A
OROXF Orosur Mining	N/A
RNUGF ReNeuron Group	N/A
WCAGY Wirecard	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DGNOF DIAGNOS	N/A	76.65 million	N/A	Not Optionable
OROXF Orosur Mining	7	205.58 million	N/A	Not Optionable
RNUGF ReNeuron Group	26	57.17 million	N/A	Not Optionable
WCAGY Wirecard	5,685	247.13 million	N/A	Not Optionable

OROXF, RNUGF, WCAGY, and DGNOF Headlines

Source	Headline
	German watchdog finds EY’s Wirecard audits grossly negligent ft.com - April 16 at 9:55 AM
	Fugitive Former Wirecard COO Unmasked as Alleged Russian Spymaster westislandblog.com - April 10 at 7:03 PM
	Wirecard shareholders suing audit giant EY Germany over asset-stripping claims msn.com - April 8 at 4:16 PM
	Wirecard shareholders sue EY over alleged asset stripping in Germany irishtimes.com - April 8 at 10:53 AM
	EY drops appeal against German sanctions over Wirecard audits ft.com - March 26 at 9:28 PM
	I exposed Wirecard's fraud - now I'll help others do the same: Whistleblower Pav Gill on new start-up msn.com - March 15 at 4:53 AM
	Wirecard lobbyist gained access to the most secret files krone.at - March 14 at 6:52 PM
	Jan Marsalek, from Wirecard fraudster to spy for Russia lemonde.fr - March 8 at 5:29 PM
	Former COO of Wirecard Jan Marsalek Was a Russian Spy, Now Lives in Russia crowdfundinsider.com - March 6 at 7:21 PM
	Ernst & Young Unit’s Wirecard Fraud Suit Victory Draws Appeal news.bloomberglaw.com - March 4 at 2:12 PM
	Vanished Wirecard executive thought to be living as Orthodox priest in Russia irishtimes.com - March 4 at 4:11 AM
	Wirecard fugitive Jan Marsalek recruited by Russian intelligence in 2014, says report ft.com - March 1 at 1:21 PM
	Wirecard whistleblower launches confidential reporting tool finextra.com - February 28 at 7:45 AM
	Wirecard whistleblower slams new German law as too weak ft.com - February 27 at 8:42 AM
	Indian-Origin Man Jailed As Director Of Company Involved In Wirecard Money ndtv.com - February 8 at 12:08 AM
	Jail for company director who was unaware his firm received over $78m from Wirecard straitstimes.com - February 7 at 8:44 AM
	Wirecard trial's key witness released from custody after 3.5 years news.yahoo.com - February 6 at 5:42 PM
	The Japanese cosmetics retailer who became a surprise witness at the Wirecard trial ft.com - January 26 at 11:24 AM
	The hedgies who sniffed out Wirecard have a new target: the AI bubble msn.com - January 23 at 3:23 PM
	Wirecard case against EY claims €1.5 billion in damages rte.ie - December 29 at 3:17 PM
	Wirecard insolvency administrator demands €1.5 billion from EY news.yahoo.com - December 29 at 3:17 PM
	Wirecard lawsuit against EY claims 1.5 billion euros in damages msn.com - December 29 at 3:17 PM
	Germany: Investors seek compensation over Wirecard fiasco msn.com - December 22 at 10:04 PM
	Wirecard investor lawsuit against EY filed in Munich msn.com - December 22 at 12:03 PM

New MarketBeat Followers Over Time

Company Descriptions

DIAGNOS

OTCMKTS:DGNOF

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Orosur Mining

OTCMKTS:OROXF

Orosur Mining Inc. engages in identifying and advancing mineral projects in South America. Its flagship project is the Anzá gold project located in the Middle Cauca Belt in northern Colombia. The company was formerly known as Uruguay Mineral Exploration Inc. and changed its name to Orosur Mining Inc. in January 2010. Orosur Mining Inc. was incorporated in 1996 and is based in Toronto, Canada.

ReNeuron Group

OTCMKTS:RNUGF

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Wirecard

OTCMKTS:WCAGY

Wirecard AG engages in the provision of software and information technology for payment processing and issuing products in the field of outsourcing and white label industry. It operates through the following segments: Payment Processing and Risk Management (PP&RM); Acquiring and Issuing (A&I); and Call Center and Communication Services (CC&CS). The PP&RM segment refers to products and services related to electronic payment processing, risk management, and other value added services. The A&I segment offers settlement services for credit card sales for online and terminal payments. The CC&CS segment reports the complete value-added scope of its call center activities, with other products. The company was founded on May 6, 1999 and is headquartered in Munich, Germany.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial